Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Benign prostatic hyperplasia: a population-based study.

C G Chute1, W P Stephenson, H A Guess

  • 1Mayo Clinic, Rochester, Minnesota.

European Urology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The WHO ICD-11 Classification of Dermatological Diseases: a new comprehensive online skin disease taxonomy designed by and for dermatologists.

The British journal of dermatology·2021
Same author

Health Concept and Knowledge Management: Twenty-five Years of Evolution.

Yearbook of medical informatics·2016
Same author

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.

Clinical pharmacology and therapeutics·2016
Same author

A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough.

The pharmacogenomics journal·2015
Same author

Harmonization of detailed clinical models with clinical study data standards.

Methods of information in medicine·2014
Same author

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.

Clinical pharmacology and therapeutics·2014
Same journal

Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.

European urology·2026
Same journal

Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436.

European urology·2026
Same journal

In Memory of Paul Mitrofanoff (1934-2025).

European urology·2026
Same journal

Re: McKay RR, Pal S, Xie W, et al. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert Consensus on the Management of Renal Cell and Urinary Tract Cancers. CA Cancer J Clin 2026;76:e70052.

European urology·2026
Same journal

Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.

European urology·2026
Same journal

Re: Alexander D. Sherry, Van To, Criselle D'souza, et al. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024.

European urology·2026
See all related articles

Initial surgery for benign prostatic hyperplasia (BPH) in Rochester, MN, showed a 15.1% reoperation risk within six years. Postoperative mortality was not significantly different from expected rates, offering insights into BPH management.

Area of Science:

  • Urology
  • Surgical Outcomes
  • Public Health

Background:

  • Benign prostatic hyperplasia (BPH) is a common urologic condition affecting aging men.
  • Understanding the natural history and surgical outcomes of BPH is crucial for effective patient management.
  • Population-based studies provide valuable insights into disease incidence and treatment efficacy.

Purpose of the Study:

  • To assess the incidence and outcomes of initial surgery for benign prostatic hyperplasia (BPH).
  • To clarify the natural occurrence and progression of urologic diseases.
  • To inform the management strategies for BPH through population-based data.

Main Methods:

  • A population-based study followed 330 men undergoing prostatectomy for BPH in Rochester, MN.

Related Experiment Videos

  • Data collected included intraoperative complications, 30-day rehospitalizations, and other serious complications.
  • Reoperation risk and postoperative mortality were analyzed over a 6-year period.

    • Main Results:

    • 14.2% experienced intraoperative complications, and 9.7% were rehospitalized for urologic issues within 30 days.
    • 14% required blood transfusions post-surgery.
    • The 6-year risk of reoperation was 15.1%, with no significant difference in postoperative mortality compared to expected rates.

    Conclusions:

    • Initial BPH surgery carries a notable risk of complications and reoperation.
    • Population-based data suggest that BPH surgery outcomes are generally favorable regarding mortality.
    • Further analysis is expected to refine understanding of BPH treatment utility and management.